Amphivena Therapeutics appoints president and CEO
Amphivena Therapeutics Inc, a private clinical stage immuno-oncology company, has named Dr. Curtis L. Ruegg as president and CEO.
Amphivena Therapeutics Inc, a private clinical stage immuno-oncology company, has named Dr. Curtis L. Ruegg as president and CEO.
Copyright PEI Media
Not for publication, email or dissemination